|
Post-operative treatment
|
Pre-operative documentation
|
YES
|
NO
|
YES
|
YES
|
NO
|
YES
|
|
Bacteriological documentation
|
MSSA
|
MSSA
|
SAMS
|
E. faecalis
|
MSSA
|
S. agalactiae
|
|
Narrow-spectrum antibiotic
|
99% (36.25/36.5)
|
NA
|
NA
|
24% (12/50)
|
NA
|
45% (14/31)
|
|
Broad-spectrum antibiotic
|
0%
|
NA
|
NA
|
43% (21.5/50)
|
NA
|
52% (16/31)
|
|
Oral antibiotic
|
Rifampicine + quinolones
|
70% (28/40)
|
92% (33.5/36.5)
|
NA
|
NA
|
90% (19/21)
|
NA
|
|
Total antibiotic regimen after DAIR
|
3 weeks
|
6% (2/36)
|
NA
|
NA
|
NA
|
NA
| |
|
4 weeks
|
35% (12.5/36)
| |
|
6 weeks
|
53% (0.5/36)
|
26% (6/23.5)
|
|
8 weeks
|
1% (0.5/36
| |
|
3 months
|
3% (1/36)
|
68% (16/23.5)
|
|
Suspensive
|
NA
|
4% (1/23.5)
|
